The CRO for CNS
The only CRO focused exclusively on central nervous system (CNS) drug development, an area of significant unmet need.
Substance Use Disorders
Mental Health
Neurological Disorders
Rare and Ultra-Rare CNS Diseases
Bringing new therapies to patients living with mental health, neurological and substance use disorders.
Experience, Scientific Knowledge and Operational Expertise Combine With Accountability, Responsibility and Integrity
Latest News & Updates
With a Pandemic Push, DCTs Are a ‘Virtual’ Lock to Go Big in ‘21
2020 will go down as a miserable year, but beyond the heartache, some developments may represent bright spots that light [...]
T3D Therapeutics selects Clinilabs Drug Development Corporation as contract research organization partner for Phase 2 trial of T3D-959 in patients with Alzheimer’s Disease.
T3D Therapeutics, Inc. (“T3D Therapeutics” or the “Company”), a biopharmaceutical company specializing in the development of ‘First-in-Class’ and ‘Best-in-Class’ disease-modifying, breakthrough [...]
Supporting Our Patients and Research Subjects Amidst COVID-19 Concerns
By now, you have likely heard about the Coronavirus (officially called “2019-Novel Coronavirus” or “COVID-19”) in the news. While the [...]
Connect With Us
Connect with us online, or come visit us at
an upcoming industry event!
AAN 2021 Virtual Annual Meeting
April 17 @ 8:00 am - April 22 @ 5:00 pmWebinar: Psychedelics for the Treatment of Depression and Psychiatric Disorders
May 25 @ 7:00 pm - 8:30 pm at VirtualSLEEP 2021
June 12 @ 8:00 am - June 16 @ 5:00 pm at Virtual
A PATIENT-CENTRIC APPROACH TO CLINICAL TRIALS
Volunteers & Patients
We empower study participants by educating them about clinical research, enabling them to make informed decisions regarding study participation.
NEW POSSIBILITIES FOR
Investigators
Clinilabs collaborates with investigator sites worldwide to conduct clinical trials that lead to new drug approvals. Become an investigator in our global network!